Patients
Continence, urinary incontinence, diabetes
URINARY INCONTINENCE, MALIGNANT TUMOR, PATHOLOGY, DISEASES, DIABETES
Patients with POP who had received pelvic floor reconstructive surgery from March 2021 to March 2022 were included in this study.The inclusion criteria were as follows: (1) patients with POP diagnosed according to the International Continence Society and International Urogynecological Association [The main exclusion criteria were as follows: (1) patients who needed for postoperative radiotherapy, chemotherapy, or hormone therapy as confirmed by postoperative pathology; (2) pregnant or lactating women; (3) patients with malignant tumor, diabetes, and other serious medical diseases; (4) patients receiving treatment of urinary incontinence drugs after surgery; (5) patients with cardiac pacemaker implantation.